The Quality and Impact of Risk Factor Control in Patients With Stable Claudication Presenting for Peripheral Vascular Interventions | Zendy

Amer Ardati | Zendy; Samuel R. Kaufman | Zendy; Herbert D. Aronow | Zendy; Timothy J. Nypaver | Zendy; Paul Bove | Zendy; Hitinder S. Gurm | Zendy; Paul Grossman | Zendy

Open Access

The Quality and Impact of Risk Factor Control in Patients With Stable Claudication Presenting for Peripheral Vascular Interventions

Author(s) -

Amer Ardati,

Samuel R. Kaufman,

Herbert D. Aronow,

Timothy J. Nypaver,

Paul Bove,

Hitinder S. Gurm,

Paul Grossman

Publication year - 2012

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.112.975862

Subject(s) - medicine , claudication , aspirin , vascular disease , intermittent claudication , peripheral , population , cardiology , atherectomy , revascularization , odds ratio , surgery , myocardial infarction , arterial disease , restenosis , stent , environmental health

Peripheral arterial disease is a manifestation of systemic atherosclerosis and is predictive of future cardiovascular events. Clinical trial data have demonstrated that medical therapy can attenuate cardiovascular morbidity and mortality in patients with peripheral arterial disease. The utilization and impact of recommended medical therapy in a contemporary population of patients who undergo percutaneous interventions for lifestyle-limiting peripheral arterial disease is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research